Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2010 Nov 1;55(3):330–335. doi: 10.1097/QAI.0b013e3181e583da

Table 3. Univariate and Multivariate Cox Proportional Hazard Ratio Modeling of Time to Progression.

Univariate Multivariate
Baseline Measure HR* (95% CI) p-value HR* (95% CI) p-value
CD4% (per 10% point decrease) 2.0 (1.8-2.2) 0.005 2.0 (1.8-2.1) 0.013
Log HIV RNA, copies/ml (per unit log increase) 2.4 (1.9-3.0) 0.002 1.8 (1.1-3.2) 0.034
% CD4 Cell Activation^ (per 10% increase) 1.6 (1.5-1.6) 0.05
% CD8 Cell Activation ^ (per 10% increase) 1.3 (1.3-1.3) 0.05
Hemoglobin < 9 g/dl 3.1 (1.9-4.3) 0.06
HIV RNA > 100,000 (c/ml) 2.0 (1.4-2.7) 0.04
CD4% < 25% 1.6 (0.9-2.3) 0.16
Male~ 2.0 (1.3-2.6) 0.04
Z-Score Weight-for-Age 0.9 (0.6-1.1) 0.21
Age (per year increase) 0.9 (0.7-1.0) 0.09
Age < 3 3.7 (1.7-8.0) 0.001 3.0 (1.3-7.0) 0.008
CD4 count (cells/μl,, per 100 cell increase) 1.0 (1.0-1.0) 0.53
*

Hazard Ratio

^

% of cells expressing both CD38+HLADR+

~

did not remain significant when adjusted for HIV RNA.